Table 3.

Heterogeneity analyses for eight publicly available models

First author; publication year	All data (P)	ER− (P)	ER+ (P)	LN+ (P)	LN− (P)
Nagalla et al29 2013	0.13	0.01	0.08	0.63	0.25
Teschendorff et al25 2007	0.01	0.05	0.07	0.91	0.14
Oh et al27 2012	0.12	0.02	0.07	0.68	0.01
Ursini-Siegel et al31 2010	0.18	0.13	0.30	0.47	0.01
Teschendorff et al26 2010	0.01	0.38	0.03	0.47	0.08
Bianchini et al28 2010	0.07	0.01	0.04	0.02	0.01
Cheng et al32 2013	0.01	0.08	0.33	0.67	0.97
Yau et al30 2010	0.15	0.29	0.31	0.99	0.16

Note: P-values of heterogeneity analyses in validation data sets are presented when analyzing all the data, ER−, ER+, LN+, and LN− cohorts, respectively.

Abbreviations: ER, estrogen receptor; LN, lymph node.